Literature DB >> 27414720

Magnitude of QRS duration reduction after biventricular pacing identifies responders to cardiac resynchronization therapy.

Giuseppe Coppola1, Gianfranco Ciaramitaro2, Giuseppe Stabile3, Antonio DOnofrio4, Pietro Palmisano5, Patrizia Carità2, Giosuè Mascioli6, Domenico Pecora7, Antonio De Simone8, Massimiliano Marini9, Antonio Rapacciuolo10, Gianluca Savarese11, Giampiero Maglia12, Patrizia Pepi13, Luigi Padeletti14, Attilio Pierantozzi15, Giuseppe Arena16, Tiziana Giovannini17, Salvatore Ivan Caico18, Cinzia Nugara2, Laura Ajello2, Maurizio Malacrida19, Egle Corrado2.   

Abstract

BACKGROUND: Several studies have investigated the association between native QRS duration (QRSd) or QRS narrowing and response to biventricular pacing. However, their results have been conflicting. The aim of our study was to determine the association between the relative change in QRS narrowing index (QI) and clinical outcome and prognosis in patients who undergo cardiac resynchronization therapy (CRT) implantation. METHODS AND
RESULTS: We included 311 patients in whom a CRT device was implanted in accordance with current guidelines for CRT. On implantation, the native QRS, the QRSd and the QI during CRT were measured. After 6months, 220 (71%) patients showed a 10% reduction in LVESV. The median [25th-75th] QI was 14.3% [7.2-21.4] and was significantly related to reverse remodeling (r=+0.22; 95%CI: 0.11-0.32, p=0.0001). The cut-off value of QI that best predicted LV reverse remodeling after 6months of CRT was 12.5% (sensitivity=63.6%, specificity=57.1%, area under the curve=0.633, p=0.0002). The time to the event death or cardiovascular hospitalization was significantly longer among patients with QI>12.5% (log-rank test, p=0.0155), with a hazard ratio (HR) of 0.3 [95%CI: 0.11-0.78]. In the multivariate regression model adjusted for baseline parameters, a 10% increment in QI (HR=0.61[0.44-0.83], p=0.002) remained significantly associated with CRT response.
CONCLUSIONS: Patients with a larger decrease in QRSd after CRT initiation showed greater echocardiographic reverse remodeling and better outcome from death or cardiovascular hospitalization. QI is an easy-to-measure variable that could be used to predict CRT response at the time of pacing site selection or pacing configuration programming.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; ECG; Heart failure; Pacing; Reverse remodeling

Mesh:

Year:  2016        PMID: 27414720     DOI: 10.1016/j.ijcard.2016.06.203

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Precision of automated QRS duration measurement in patients treated with cardiac resynchronization therapy.

Authors:  Casper Lund-Andersen; Helen H Petersen; Christian Jøns; Berit T Philbert; Jacob Tfelt-Hansen; Lene T Skovgaard; Jesper H Svendsen
Journal:  J Interv Card Electrophysiol       Date:  2018-03-05       Impact factor: 1.900

2.  Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based strategy for congenital heart disease.

Authors:  Aya Miyazaki; Jun Negishi; Yosuke Hayama; Shigehito Baba; Yu Matsumura; Yuriko Shima; Etusko Tsuda; Heima Sakaguchi; Takaya Hoashi; Koji Kagisaki; Takashi Noda; Hiraku Doi; Hajime Ichikawa; Hideo Ohuchi
Journal:  Heart Vessels       Date:  2019-03-12       Impact factor: 2.037

3.  Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies.

Authors:  George Bazoukis; Katerina K Naka; Alawi Alsheikh-Ali; Gary Tse; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Cynthia Yeung; Michael Efremidis; Konstantinos Tsioufis; Adrian Baranchuk; Stavros Stavrakis
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

4.  Programming Cardiac Resynchronization Therapy for Electrical Synchrony: Reaching Beyond Left Bundle Branch Block and Left Ventricular Activation Delay.

Authors:  Niraj Varma; David O'Donnell; Mohammed Bassiouny; Philippe Ritter; Carlo Pappone; Jan Mangual; Daniel Cantillon; Nima Badie; Bernard Thibault; Brian Wisnoskey
Journal:  J Am Heart Assoc       Date:  2018-02-06       Impact factor: 5.501

5.  Left bundle branch area pacing delivery of cardiac resynchronization therapy and comparison with biventricular pacing.

Authors:  Xiaofei Li; Chunguang Qiu; Ruiqin Xie; Wentao Ma; Zhao Wang; Hui Li; Hao Wang; Wei Hua; Shu Zhang; Yan Yao; Xiaohan Fan
Journal:  ESC Heart Fail       Date:  2020-05-13

6.  The relationship between ECG predictors of cardiac resynchronization therapy benefit.

Authors:  Josef Halamek; Pavel Leinveber; Ivo Viscor; Radovan Smisek; Filip Plesinger; Vlastimil Vondra; Jolana Lipoldova; Magdalena Matejkova; Pavel Jurak
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

7.  Cardiac resynchronization therapy with multipoint pacing in a patient with cancer therapeutics-related cardiac dysfunction.

Authors:  Cristiano Massacesi; Laura Ceriello; Enrico Di Girolamo
Journal:  Clin Case Rep       Date:  2019-05-16

8.  Can machine learning improve patient selection for cardiac resynchronization therapy?

Authors:  Szu-Yeu Hu; Enrico Santus; Alexander W Forsyth; Devvrat Malhotra; Josh Haimson; Neal A Chatterjee; Daniel B Kramer; Regina Barzilay; James A Tulsky; Charlotta Lindvall
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

9.  Left ventricular paced activation in cardiac resynchronization therapy patients with left bundle branch block and relationship to its electrical substrate.

Authors:  Brian J Wisnoskey; Niraj Varma
Journal:  Heart Rhythm O2       Date:  2020-05-11

10.  A case of modern management of Morgagni-Adam-Stokes syndrome.

Authors:  Maria Silvia Negroni; Francesca Furia; Francesca Bursi; Maria Paola Canevini; Stefano Carugo
Journal:  Clin Case Rep       Date:  2019-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.